| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |